pravastatin has been researched along with Arrhythmias, Cardiac in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CC; Hsu, YJ; Lee, TM; Lien, HY; Lin, CC; Shih, CM | 1 |
| Saito, Y; Sasaki, N; Shinomiya, M; Shirai, K; Yoshida, S | 1 |
| Can, L; Evrengul, H; Kayikcioglu, M; Kultursay, H; Payzin, S | 1 |
| Diener, HC | 1 |
| Chen, J; Fujimura, A; Harada, K; Hashimoto, K; Nagasawa, Y; Ohmori, M; Zhu, BM | 1 |
| Chen, J; Hashimoto, K; Mitsui, K; Nagasawa, Y; Shen, H; Tsurugi, K | 1 |
2 trial(s) available for pravastatin and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Prognosis of hypercholesterolemic patients taking pravastatin for five years: the Chiba Lipid Intervention Program (CLIP) Study.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Anticholesteremic Agents; Arrhythmias, Cardiac; Cause of Death; Female; Follow-Up Studies; Heart Failure; Humans; Hypercholesterolemia; Incidence; Lipids; Male; Middle Aged; Myocardial Infarction; Pravastatin; Prognosis; Prospective Studies; Risk Factors | 2002 |
The effect of statin therapy on ventricular late potentials in acute myocardial infarction.
Topics: Adult; Aged; Arrhythmias, Cardiac; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Fibrinolytic Agents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Pravastatin; Prospective Studies; Time Factors; Ventricular Dysfunction, Left | 2003 |
4 other study(ies) available for pravastatin and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Effect of pravastatin on ventricular arrhythmias in infarcted rats: role of connexin43.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blotting, Western; Bosentan; Cardiac Pacing, Artificial; Connexin 43; Disease Models, Animal; Drug Therapy, Combination; Endothelin Receptor Antagonists; Endothelin-1; Fluorescent Antibody Technique; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Male; Maleimides; Mevalonic Acid; Myocardial Infarction; Myocardium; Pravastatin; Protein Kinase C; Protein Kinase Inhibitors; Rats; Rats, Wistar; Receptors, Endothelin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Time Factors; Ultrasonography | 2010 |
[Primary prevention of stroke. What helps--what does not help? The guidelines of the German Society of Neurology briefly summarized].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Alcohol Drinking; Anticholesteremic Agents; Anticoagulants; Antihypertensive Agents; Arrhythmias, Cardiac; Aspirin; Atenolol; Atrial Fibrillation; Carotid Artery, Internal; Carotid Stenosis; Chlorthalidone; Clinical Trials as Topic; Diabetes Complications; Diuretics; Doxazosin; Female; Fibrinolytic Agents; Hormone Replacement Therapy; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Life Style; Losartan; Male; Neurology; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Pravastatin; Primary Prevention; Risk Factors; Simvastatin; Smoking; Societies, Medical; Stroke | 2003 |
Pravastatin prevents arrhythmias induced by coronary artery ischemia/reperfusion in anesthetized normocholesterolemic rats.
Topics: Anesthesia; Animals; Arrhythmias, Cardiac; Cholesterol; Dose-Response Relationship, Drug; Male; Myocardial Reperfusion Injury; Pravastatin; Rats; Rats, Sprague-Dawley | 2003 |
Pravastatin inhibits arrhythmias induced by coronary artery ischemia in anesthetized rats.
Topics: Administration, Oral; Anesthesia; Animals; Arrhythmias, Cardiac; Coronary Vessels; Dose-Response Relationship, Drug; Drug Administration Schedule; Fatty Acids, Monounsaturated; Fluvastatin; Hydroxymethylglutaryl CoA Reductases; Indoles; Ischemia; Male; Peroxidase; Pravastatin; Rats; Rats, Sprague-Dawley | 2007 |